Related Experiment Videos
DNA Containing Bioactive CpG Motifs Promote Angiogenesis
Drug News & Perspectives
|April 5, 2003
Summary
CpG DNA, found in viruses like HSV, stimulates new blood vessel formation (angiogenesis). This process involves vascular endothelial growth factor (VEGF) and may offer therapeutic benefits for revascularization.
Area of Science:
- Immunology
- Molecular Biology
- Vascular Biology
Background:
- Unmethylated CpG motifs are prevalent in microbial DNA, including herpes simplex virus (HSV).
- These CpG motifs possess inherent bioactivity, stimulating immune and central nervous system cells.
Purpose of the Study:
- To investigate whether DNA containing CpG motifs can promote angiogenesis in vivo.
- To determine if CpG DNA directly or indirectly induces the formation of new blood vessels.
Main Methods:
- Administered purified HSV DNA and synthetic CpG oligodeoxynucleotides (ODN) in vivo.
- Assessed new blood vessel formation and vascular endothelial growth factor (VEGF) production.
- Utilized anti-VEGF antibodies to block the angiogenic effect.
Main Results:
- Both HSV DNA and synthetic CpG ODN significantly stimulated new blood vessel formation.
- The observed angiogenesis was linked to increased vascular endothelial growth factor (VEGF) production.
- Co-administration of anti-VEGF antibodies abrogated the CpG-induced angiogenesis.
Conclusions:
- Bioactive CpG motifs in DNA can induce VEGF production, thereby promoting angiogenesis.
- CpG ODN holds potential as a therapeutic agent for conditions requiring revascularization.